Cite
MLA Citation
Antonios O. Aliprantis et al.. “A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults.” Clinical pharmacology in drug development, vol. 10, no. 5, 2021, pp. 556–566. http://access.bl.uk/ark:/81055/vdc_100129522139.0x000006